Literature DB >> 7866378

Ischaemic heart disease: disability and costs.

S O Isacsson1.   

Abstract

Ischaemic heart disease is responsible for a considerable part of chronic pain in society, and is mainly due to angina pectoris. Improvements in pain relief and treatment continue to be developed, and are likely to improve and become cheaper in the future. Prevention is also of great importance for both individuals and society, and is proving cost-effective. However, we have still to learn much about its complex nature.

Entities:  

Mesh:

Year:  1994        PMID: 7866378     DOI: 10.1007/bf00433382

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  3 in total

1.  [Epidemiologic surveillance of myocardial infarction shows fewer cases but large regional differences].

Authors:  N Hammar; E Sandberg; A Ahlbom; L Alfredsson; A Leimanis
Journal:  Lakartidningen       Date:  1991-05-08

2.  Prevalence of angina pectoris and myocardial infarction in a general population sample of Swedish men.

Authors:  M Hagman; D Jönsson; L Wilhelmsen
Journal:  Acta Med Scand       Date:  1977

3.  [Occurrence of angina pectoris in Skaraborg county].

Authors:  J Väärt; B Haglund; S O Isacsson; L Rydén
Journal:  Lakartidningen       Date:  1981-09-23
  3 in total
  3 in total

1.  Household income losses associated with ischaemic heart disease for US employees.

Authors:  J Herrin; C B Cangialose; S J Boccuzzi; W S Weintraub; D J Ballard
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

2.  Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics.

Authors:  Cielito C Reyes-Gibby; Lu Ann Aday; Knox H Todd; Charles S Cleeland; Karen O Anderson
Journal:  J Pain       Date:  2006-09-01       Impact factor: 5.820

3.  Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.

Authors:  Cielito C Reyes-Gibby; Wenyaw Chan; James L Abbruzzese; Henry Q Xiong; Linus Ho; Douglas B Evans; Gauri Varadhachary; Samrat Bhat; Robert A Wolff; Christopher Crane
Journal:  J Pain Symptom Manage       Date:  2007-05-21       Impact factor: 3.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.